Literature DB >> 27926546

The effect of chronic kidney disease on T cell alloimmunity.

Pamela D Winterberg1, Mandy L Ford.   

Abstract

PURPOSE OF REVIEW: Altered differentiation and activation of T-cell subsets occur in patients with chronic kidney disease (CKD), but the impact on graft rejection and protective immunity during transplantation are not fully understood. RECENT
FINDINGS: Patients with CKD have decreased frequency of naïve T cells, accumulation of activated, terminally differentiated memory cells, and skewed regulatory versus T helper 17 ratio. Naïve and memory T-cell subsets do not appear to improve following kidney transplantation. Retained thymic output is associated with acute rejection, whereas naïve lymphopenia and accumulation of CD8 TEMRA cells correlate with long-term graft dysfunction. CD28 memory cells accumulate during CKD and appear to confer protection against acute rejection under standard immunosuppression and possibly costimulation blockade. T cells bearing CD57 are also increased in patients with CKD and may underlie rejection during costimulation blockade.
SUMMARY: The mechanisms by which CKD alters the differentiation and activation status of T-cell subsets is poorly understood. Further research is also needed to understand which cell populations mediate rejection under various immunosuppressive regimens. To date, there is little use of animal models of organ failure in transplant immunology research. CKD mouse models may help identify novel pathways and targets to better control alloimmunity in posttransplant.

Entities:  

Mesh:

Year:  2017        PMID: 27926546      PMCID: PMC5412080          DOI: 10.1097/MOT.0000000000000375

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  47 in total

1.  Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease.

Authors:  Pascal Meier; Eric Dayer; Edouard Blanc; Jean-Pierre Wauters
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

2.  Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry.

Authors:  Judith L Vogelzang; Karlijn J van Stralen; Marlies Noordzij; Jose Abad Diez; Juan J Carrero; Cecile Couchoud; Friedo W Dekker; Patrik Finne; Denis Fouque; James G Heaf; Andries Hoitsma; Torbjørn Leivestad; Johan de Meester; Wendy Metcalfe; Runolfur Palsson; Maurizio Postorino; Pietro Ravani; Raymond Vanholder; Manfred Wallner; Christoph Wanner; Jaap W Groothoff; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2015-01-29       Impact factor: 5.992

3.  Oxidative stress is progressively enhanced with advancing stages of CKD.

Authors:  Evangelia Dounousi; Eleni Papavasiliou; Areti Makedou; Kyriakos Ioannou; Konstantinos P Katopodis; Alexandros Tselepis; Kostas C Siamopoulos; Dimitrios Tsakiris
Journal:  Am J Kidney Dis       Date:  2006-11       Impact factor: 8.860

4.  Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients.

Authors:  Edith M Simmons; Anthony Langone; M Tugrul Sezer; John P Vella; Peter Recupero; Jason D Morrow; T Alp Ikizler; Jonathan Himmelfarb
Journal:  Transplantation       Date:  2005-04-27       Impact factor: 4.939

5.  Effect of waiting time on renal transplant outcome.

Authors:  H U Meier-Kriesche; F K Port; A O Ojo; S M Rudich; J A Hanson; D M Cibrik; A B Leichtman; B Kaplan
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

6.  Hemodialysis vintage, black ethnicity, and pretransplantation antidonor cellular immunity in kidney transplant recipients.

Authors:  Joshua J Augustine; Emilio D Poggio; Michael Clemente; Mark I Aeder; Kenneth A Bodziak; James A Schulak; Peter S Heeger; Donald E Hricik
Journal:  J Am Soc Nephrol       Date:  2007-03-27       Impact factor: 10.121

7.  Long time follow up of CD28- CD4+ T cells in living kidney transplant patients.

Authors:  M Kato; Y Ono; T Kinukawa; R Hattori; O Kamihira; S Ohshima
Journal:  Clin Transplant       Date:  2004-06       Impact factor: 2.863

8.  Erythropoietin increases macrophage-mediated T cell suppression.

Authors:  Michelle A Wood; Naomi Goldman; Kelley DePierri; John Somerville; James E Riggs
Journal:  Cell Immunol       Date:  2016-05-27       Impact factor: 4.868

Review 9.  Immune cell dysfunction and inflammation in end-stage renal disease.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

Review 10.  Vitamin D in renal transplantation - from biological mechanisms to clinical benefits.

Authors:  R McGregor; G Li; H Penny; G Lombardi; B Afzali; D J Goldsmith
Journal:  Am J Transplant       Date:  2014-05-19       Impact factor: 8.086

View more
  5 in total

1.  Selective CD28 blockade attenuates CTLA-4-dependent CD8+ memory T cell effector function and prolongs graft survival.

Authors:  Danya Liu; I Raul Badell; Mandy L Ford
Journal:  JCI Insight       Date:  2018-01-11

2.  Prevalence and risk of chronic kidney disease in oral lichen planus: a large cross-sectional study from eastern China.

Authors:  Yiwen Deng; Chengyi Wang; Yeqing Shen; Bo Shen; Feng Ding; Guoyao Tang; Wei Liu
Journal:  Ann Transl Med       Date:  2021-07

3.  End-stage renal disease, dialysis, kidney transplantation and their impact on CD4+ T-cell differentiation.

Authors:  Matthias Schaier; Angele Leick; Lorenz Uhlmann; Florian Kälble; Christian Morath; Volker Eckstein; Anthony Ho; Carsten Mueller-Tidow; Stefan Meuer; Karsten Mahnke; Claudia Sommerer; Martin Zeier; Andrea Steinborn
Journal:  Immunology       Date:  2018-05-25       Impact factor: 7.397

Review 4.  Immunological Effects of a Single Hemodialysis Treatment.

Authors:  Andrea Angeletti; Fulvia Zappulo; Chiara Donadei; Maria Cappuccilli; Giulia Di Certo; Diletta Conte; Giorgia Comai; Gabriele Donati; Gaetano La Manna
Journal:  Medicina (Kaunas)       Date:  2020-02-12       Impact factor: 2.430

5.  Kidney Failure Associates With T Cell Exhaustion and Imbalanced Follicular Helper T Cells.

Authors:  Susan Hartzell; Sofia Bin; Chiara Cantarelli; Meredith Haverly; Joaquin Manrique; Andrea Angeletti; Gaetano La Manna; Barbara Murphy; Weijia Zhang; Josh Levitsky; Lorenzo Gallon; Samuel Mon-Wei Yu; Paolo Cravedi
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.